Related references
Note: Only part of the references are listed.Engineering antibody-like inhibitors to prevent and treat HIV-1 infection
Matthew R. Gardner et al.
CURRENT OPINION IN HIV AND AIDS (2017)
Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth
Jinghe Huang et al.
IMMUNITY (2016)
Quantitative Correlation between Infectivity and Gp120 Density on HIV-1 Virions Revealed by Optical Trapping Virometry
Michael C. DeSantis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
CD4-Induced Antibodies Promote Association of the HIV-1 Envelope Glycoprotein with CD4-Binding Site Antibodies
Matthew R. Gardner et al.
JOURNAL OF VIROLOGY (2016)
Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C
Kshitij Wagh et al.
PLOS PATHOGENS (2016)
NK Cells in HIV Disease
Eileen Scully et al.
CURRENT HIV/AIDS REPORTS (2016)
AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges
Matthew R. Gardner et al.
NATURE (2015)
Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy
Anthony P. West et al.
CELL (2014)
Exceptionally Potent and Broadly Cross-Reactive, Bispecific Multivalent HIV-1 Inhibitors Based on Single Human CD4 and Antibody Domains
Weizao Chen et al.
JOURNAL OF VIROLOGY (2014)
Optical trapping of individual human immunodeficiency viruses in culture fluid reveals heterogeneity with single-molecule resolution
Yuanjie Pang et al.
NATURE NANOTECHNOLOGY (2014)
HIV-1 neutralizing antibodies: understanding nature's pathways
John R. Mascola et al.
IMMUNOLOGICAL REVIEWS (2013)
Enhanced Recognition and Neutralization of HIV-1 by Antibody-Derived CCR5-Mimetic Peptide Variants
Jessica J. Chiang et al.
JOURNAL OF VIROLOGY (2012)
Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family
Mattia Bonsignori et al.
JOURNAL OF VIROLOGY (2012)
A Novel Assay for Antibody-Dependent Cell-Mediated Cytotoxicity against HIV-1-or SIV-Infected Cells Reveals Incomplete Overlap with Antibodies Measured by Neutralization and Binding Assays
Michael D. Alpert et al.
JOURNAL OF VIROLOGY (2012)
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
Jinghe Huang et al.
NATURE (2012)
Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies
Hugo Mouquet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
HIV: Cell Binding and Entry
Craig B. Wilen et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
ADCC Develops Over Time during Persistent Infection with Live-Attenuated SIV and Is Associated with Complete Protection against SIVmac251 Challenge
Michael D. Alpert et al.
PLOS PATHOGENS (2012)
HIV-1 Envelope Glycoprotein Biosynthesis, Trafficking, and Incorporation
Mary Ann Checkley et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
A Tyrosine-Sulfated CCR5-Mimetic Peptide Promotes Conformational Transitions in the HIV-1 Envelope Glycoprotein
Jo Ann Kwong et al.
JOURNAL OF VIROLOGY (2011)
Engineered Single Human CD4 Domains as Potent HIV-1 Inhibitors and Components of Vaccine Immunogens
Weizao Chen et al.
JOURNAL OF VIROLOGY (2011)
Broad neutralization coverage of HIV by multiple highly potent antibodies
Laura M. Walker et al.
NATURE (2011)
Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design
Ron Diskin et al.
SCIENCE (2011)
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
Johannes F. Scheid et al.
SCIENCE (2011)
Natural killer cells in spontaneous control of HIV infection
Christoph T. Berger et al.
CURRENT OPINION IN HIV AND AIDS (2011)
HIV-1 Entry Cofactor: Functional cDNA Cloing of a Seven-Transmembrane, G protein-Coupled Receptor
Yu Feng et al.
JOURNAL OF IMMUNOLOGY (2011)
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Xueling Wu et al.
SCIENCE (2010)
Evidence that Ecotropic Murine Leukemia Virus Contamination in TZM-bl Cells Does Not Affect the Outcome of Neutralizing Antibody Assays with Human Immunodeficiency Virus Type 1
Emily J. Platt et al.
JOURNAL OF VIROLOGY (2009)
Identification of Gammaretroviruses Constitutively Released from Cell Lines Used for Human Immunodeficiency Virus Research
Yasuhiro Takeuchi et al.
JOURNAL OF VIROLOGY (2008)
Molecular architecture of native HIV-1 gp120 trimers
Jun Liu et al.
NATURE (2008)
A tyrosine-sulfated peptide derived from the heavy-chain CDR3 region of an HIV-1-neutralizing antibody binds gp120 and inhibits HIV-1 infection
Tatyana Dorfman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies
M Li et al.
JOURNAL OF VIROLOGY (2005)
A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates
DH Barouch et al.
JOURNAL OF VIROLOGY (2005)
Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120
H Choe et al.
CELL (2003)
Antibody neutralization and escape by HIV-1
XP Wei et al.
NATURE (2003)
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy
XP Wei et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Biochemical and biological characterization of a dodecameric CD4-Ig fusion protein - Implications for therapeutic and vaccine strategies
J Arthos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule
JH Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry
M Farzan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120
CA Derdeyn et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
